While 96% of the population is located within 60 minutes of an ED with any acute stroke expertise, many smaller, critical access hospitals in rural regions still are without these lifesaving services.
The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.
The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.
An example of the CV Wizard clinical decision support (CDS) software showing a screen designed to help patients better understand their risks and areas they need to work on.
Evidence shows this technology has the potential to improve care for vulnerable patients with cardiovascular disease.